- Home
- MRUS vs DNB Comparison
MRUS vs DNB Comparison
Compare MRUS & DNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- DNB
- Stock Information
- Founded
- MRUS 2003
- DNB 1841
- Country
- MRUS Netherlands
- DNB United States
- Employees
- MRUS N/A
- DNB N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- DNB Finance: Consumer Services
- Sector
- MRUS Health Care
- DNB Finance
- Exchange
- MRUS Nasdaq
- DNB Nasdaq
- Market Cap
- MRUS 4.1B
- DNB 4.1B
- IPO Year
- MRUS 2016
- DNB 2020
- Fundamental
- Price
- MRUS $66.83
- DNB $9.09
- Analyst Decision
- MRUS Strong Buy
- DNB Hold
- Analyst Count
- MRUS 12
- DNB 6
- Target Price
- MRUS $91.00
- DNB $11.04
- AVG Volume (30 Days)
- MRUS 661.7K
- DNB 2.9M
- Earning Date
- MRUS 08-05-2025
- DNB 08-11-2025
- Dividend Yield
- MRUS N/A
- DNB 1.65%
- EPS Growth
- MRUS N/A
- DNB N/A
- EPS
- MRUS N/A
- DNB N/A
- Revenue
- MRUS $56,228,000.00
- DNB $2,406,000,000.00
- Revenue This Year
- MRUS $67.27
- DNB $4.63
- Revenue Next Year
- MRUS $0.49
- DNB $4.82
- P/E Ratio
- MRUS N/A
- DNB N/A
- Revenue Growth
- MRUS 59.77
- DNB 1.97
- 52 Week Low
- MRUS $33.19
- DNB $7.78
- 52 Week High
- MRUS $67.59
- DNB $12.95
- Technical
- Relative Strength Index (RSI)
- MRUS 64.93
- DNB 47.52
- Support Level
- MRUS $63.21
- DNB $9.06
- Resistance Level
- MRUS $67.59
- DNB $9.11
- Average True Range (ATR)
- MRUS 2.22
- DNB 0.02
- MACD
- MRUS -0.27
- DNB -0.00
- Stochastic Oscillator
- MRUS 97.33
- DNB 58.33
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About DNB Dun & Bradstreet Holdings Inc.
Dun & Bradstreet Holdings Inc is a provider of business decisioning data and analytics. The company operates in two segments: North America, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights in the United States and Canada; and International, which offers Finance & Risk and Sales & Marketing data, analytics, and business insights directly in the U.K, Europe, Greater China, India and indirectly through its WWN alliances. The company generates maximum revenue from the North American region. Other services provided by the company include digital marketing, sales acceleration, and risk management among others.